Cornell chemists contributed to Nobel Prize-winning work

As doctoral students nearly 20 years ago, two Cornell researchers played an early role in the development of the work that was awarded the 2022 Nobel Prize in chemistry.

Novel technique reveals surprising way to suppress tumor cells

By analyzing key enzymes in a new way, an international team led by researchers at Weill Cornell Medicine has discovered how a well-known signaling molecule can either stimulate or suppress tumor growth depending on where it’s produced. 

‘Our story’: Native American writers cultivate their craft

A free weekly workshop sponsored by Cornell’s Center for Cultural Humility through Oct. 24 highlights the work of upstate New York authors and helps them enhance their writing.

New tool discovers cancer-driving genes

An advanced software tool for analyzing DNA sequences from tumor samples has uncovered likely new cancer-driving genes, in a study led by Weill Cornell Medicine researchers.

Cellular process linked to postpartum depression

A cellular process known as autophagy that helps rid cells of debris may be impaired in pregnant women who go on to develop postpartum depression, according to new research from Weill Cornell Medicine.

Cross-campus initiative to accelerate innovations in engineering, medicine

Weill Cornell Medicine and Cornell Engineering are launching an initiative, led by Emmanuel Giannelis, to form cross-disciplinary partnerships.

Study sheds light on precancerous ‘clonal outgrowth’ in blood cells

The blood stem cell mutation, known as DNMT3A R882leads to the growth of a large population of circulating blood cells that also contain this mutation.

Discovery illuminates how Parkinson’s disease spreads in the brain

Aggregates of a protein spread in the brains of people with Parkinson’s disease through a cellular waste-ejection process, suggests a new study led by Weill Cornell Medicine researchers.

Aggressive breast cancer linked to African ancestry

Weill Cornell Medicine investigators have identified definitive biological links between African ancestry and disease processes that affect an aggressive cancer type called triple-negative breast cancer.